Past Issues

  1. Home
  2. Past Issues

Zithromac (azithromycin hydrate)

In October 2002, we requested Pfizer Japan Inc. and MHLW to suspend the production of Zithromac (azithromycin hydrate), because tissue half-life is long and symptoms can develop even after the patient is no longer taking the medicine and other medicine can also act as alternatives.


  • YAKUGAI Ombudsperson
  • Tie-up Group

No Related Information

Table Of Contents